BW
TEVA icon

Boaz Weinstein’s Teva Pharmaceuticals TEVA Stock Holding History

Boaz Weinstein’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,216,000
Closed -$11.8M – 759
2021
Q3 		$11.8M Sell
1,216,000
-3,173,500
-72% -$29.7M 0.29% 70
2021
Q2 		$43.5M Buy
+4,389,500
New +$46.5M 1.24% 13
2019
Q4 		– Sell
-1,775,900
Closed -$12.2M – 101
2019
Q3 		$12.2M Buy
+1,775,900
New +$13.6M 0.57% 40

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boaz Weinstein's TEVA Position: Q2 2024 in Review

Boaz Weinstein sold out of Teva Pharmaceuticals (TEVA) in Q2 2024, closing a stake of 131,005 shares — an estimated $1.85M sold.

Boaz Weinstein first reported a position in TEVA in Q3 2019 and held it in 7 quarters. The position peaked at $1.93M in Q3 2023. 534 funds tracked by Wall St. Rank hold TEVA as of Q2 2024.

  • Boaz Weinstein reported no remaining Teva Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Boaz Weinstein sold 131,005 Teva Pharmaceuticals shares in Q2 2024, an estimated $1.85M.
  • Boaz Weinstein first reported a position in Teva Pharmaceuticals in Q3 2019 and held it in 7 quarters.
  • Boaz Weinstein's Teva Pharmaceuticals position peaked at $1.93M in Q3 2023.
  • 534 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2024.

Based on Saba Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.